• PO 1: Knowledge: Studentswill have strong theoretical background along with necessary skills in pharmaceutical sciences and the abilityto apply them in research and development.
• PO 2: Core Competence: Students will be competent in the domain of specialization viz., Quality Assurance, Biological Evaluations, Regulatory Affairs, GMP, Research Methodology and Statistical Evaluation of data as per the requirement of pharmaceutical industry.
• PO 3: Breadth: Trained students will have practical efficiency in analytical techniques in drug and formulation development and inclinical research, new drug application and application of quality assurance in all aspects of drug research so that they are able to extend this knowledge to create new products for the benefit of life.
• PO 4: Preparation: Students will be prepared to excel in pharmaceutical research and also to succeed in pharmaceutical industry or academics through innovative teaching methodologies that stimulates students to self-learning and further their knowledge.
• PO 5: Professionalism: Students will be inculcated with professional values, effective research communication skills, prioritizing problems and solutions and an ability to view pharmaceutical issues in broader context.
• PO 6: Evaluation: The ability to evaluate important aspects of the matter they have studied, weigh the pros and cons of the ideology they adhere to in the field of pharmaceutical sciences.

Programme Outcome (PO)

• PO1: Life Sciences Knowledge: Impart fundamental knowledge of physiology, anatomy, biochemistry, Chemistry of organic and inorganic compounds as per themonographs
• PO2: Pathology and Pharmacology knowledge: Impart knowledge of relevant aspects of pathophysiological mechanisms, medical uses of natural drugs, and Pharmacological aspects of medicines
• PO3: Design/Development of solutions: Impart the modern concept of rational drug design such as Quantitative Structure Activity Relationship, Computer Aided Drug Design and concept of antisense molecules 
• PO4: Community Pharmacy knowledge: Imbibe skills such as dispensing of drugs, ensure safe medication usage, patient counseling and improve patient care in community pharmacy set up
• PO5: Clinical Pharmacist Knowledge: Inculcate the practical clinical discussions, attending ward rounds, follow-up progress of patients, case presentation at discharge are imbibed through hospital postings
• PO6: The Clinical Pharmacist and society – Participation in hospital camps, disease awareness programs will inculcate the social responsibility of the clinical pharmacists. Provide pharmaceutical care including Medication Therapy Management, vaccinations and drug therapy monitoring in inpatient, ambulatory and community practice
• PO7: Conduct investigations of complex problems: Understand biopharmaceutical principles and pharmacokinetic principles through different compartment models, multiple dosage regimens, non-linear pharmacokinetics, and assessment of bioavailability and bioequivalence 
• PO8: Ethics: Comprehend the clinical aspects of drug development, such as phases, ethical issues, and roles and responsibilities of clinical trial personnel, design of clinical study documents, data management and safety monitoring in clinical trials 
• PO9: Patient counseling and Pharmaceutical Care: Provide high quality, evidence-based, patient-centered care in cooperation with patients, prescribers and members of the inter-professional health care team and Promote health and wellness and disease prevention

Programme Specific Outcomes (PSO)

• PSO1: Understand various drug distribution methods, know the professional practice management skills in hospital pharmacies.
• PSO2: Recognize unbiased drug information to the healthcare providers, appreciate practice based research methods, and appreciate stores management and inventory control 
• PSO3: Preparation of personalized therapeutic strategies based on diagnosis, through identification of options, observing treatment, time-course of clinical and laboratory indices of therapeutic response and adverse effects
• PSO4: Interpret specific laboratory results of disease states, retrieve, analyze, interpret and formulate medicine information
• PSO5: Explain the drug utilization review, cohort studies, meta-analysis, prescription monitoring, risk management and pharmacoeconomic evaluation.
• PSO6: Understand the toxicological aspects of individual class of xenobiotics such as pesticides, opiates, NSAIDs, radiation, heavy metals, plant, food poisonings, and snake bites
• PSO7: Explicate patient care in performing medication history, interpretations of laboratory data, categorizing potential-medicine related impacts of Pharmacotherapy

Programme Outcome (PO)

• PO1: Life Sciences Knowledge: Impart fundamental knowledge of physiology, anatomy, biochemistry, Chemistry of organic and inorganic compounds as per themonographs
• PO2: Pathology and Pharmacology knowledge: Impart knowledge of relevant aspects of pathophysiological mechanisms, medical uses of natural drugs, and Pharmacological aspects of medicines
• PO3: Design/Development of solutions: Impart the modern concept of rational drug design such as Quantitative Structure Activity Relationship, Computer Aided Drug Design and concept of antisense molecules 
• PO4: Community Pharmacy knowledge: Imbibe skills such as dispensing of drugs, ensure safe medication usage, patient counseling and improve patient care in community pharmacy set up
• PO5: Clinical Pharmacist Knowledge: Inculcate the practical clinical discussions, attending ward rounds, follow-up progress of patients, case presentation at discharge are imbibed through hospital postings
• PO6: The Clinical Pharmacist and society – Participation in hospital camps, disease awareness programs will inculcate the social responsibility of the clinical pharmacists. Provide pharmaceutical care including Medication Therapy Management, vaccinations and drug therapy monitoring in inpatient, ambulatory and community practice
• PO7: Conduct investigations of complex problems: Understand biopharmaceutical principles and pharmacokinetic principles through different compartment models, multiple dosage regimens, non-linear pharmacokinetics, and assessment of bioavailability and bioequivalence 
• PO8: Ethics: Comprehend the clinical aspects of drug development, such as phases, ethical issues, and roles and responsibilities of clinical trial personnel, design of clinical study documents, data management and safety monitoring in clinical trials 
• PO9: Patient counseling and Pharmaceutical Care: Provide high quality, evidence-based, patient-centered care in cooperation with patients, prescribers and members of the inter-professional health care team and Promote health and wellness and disease prevention

Programme Specific Outcomes (PSO)

• PSO1: Understand various drug distribution methods, know the professional practice management skills in hospital pharmacies.
• PSO2: Recognize unbiased drug information to the healthcare providers, appreciate practice based research methods, and appreciate stores management and inventory control 
• PSO3: Preparation of personalized therapeutic strategies based on diagnosis, through identification of options, observing treatment, time-course of clinical and laboratory indices of therapeutic response and adverse effects
• PSO4: Interpret specific laboratory results of disease states, retrieve, analyze, interpret and formulate medicine information
• PSO5: Explain the drug utilization review, cohort studies, meta-analysis, prescription monitoring, risk management and pharmacoeconomic evaluation.
• PSO6: Understand the toxicological aspects of individual class of xenobiotics such as pesticides, opiates, NSAIDs, radiation, heavy metals, plant, food poisonings, and snake bites
• PSO7: Explicate patient care in performing medication history, interpretations of laboratory data, categorizing potential-medicine related impacts of Pharmacotherapy